Kintai, Studying The Enteric Signaling Pathway, Is Looking For Partners
Executive Summary
Emerging Company Profile: The start-up, funded by Flagship Pioneering, is developing small molecules across multiple therapeutic areas, based on a discovery platform exploring the microbiome, gut immune system and enteric nervous system.